Seqirus Vaccines
– Merit Holdings – Formulation Civils

Seqirus Vaccines, which is part of global biotherapeutics leader CSL Limited, developed a new £15M manufacturing facility to support the production of influenza vaccines at its Liverpool site. Working with Seqirus and Principal Contractor, Merit Holdings, Danby Projects delivered the civil and structural works to this complex and business critical project.


  • Strengthening to existing structure high specification weigh scales
  • Provision of bespoke stainless steel drainage channels
  • General structural alterations to upper floors

All projects


Contact danby for a complete project turnaround